New biomaterials for the sustained release of nitric oxide: past, present and future.

Abstract:

:Nitric oxide (NO), the 1992 'Molecule of the Year', is the focus of immense medical and scientific exploration. Interest in NO has grown exponentially since the initial and relatively recent discovery that NO is the long sought after endothelial relaxing factor. There is intense research that is continuing to expose the extensive physiologic impact of NO in virtually all organ and tissue systems under both normal and pathological conditions. Both the rate of delivery and the amount of site-specific generated NO modulate a balance between cytoregulatory and cytotoxic activities. This balancing act and the very short lifetime of NO under physiological conditions pose an extreme challenge with respect to harnessing the exceptional therapeutic potential of this molecule. Over the past two decades, the race to translate the therapeutic potential of NO to the bedside has been overwhelmingly through the development of numerous NO delivery devices/vehicles. So far no one product has emerged as a clearcut winner. This review: discusses and evaluates NO-donating platforms that are available at present; attempts to enhance delivery and efficacy through encapsulation in silane-based hydrogel matrices; and discusses and evaluates the future direction of these advances.

journal_name

Expert Opin Drug Deliv

authors

Friedman A,Friedman J

doi

10.1517/17425240903196743

subject

Has Abstract

pub_date

2009-10-01 00:00:00

pages

1113-22

issue

10

eissn

1742-5247

issn

1744-7593

journal_volume

6

pub_type

杂志文章,评审
  • Harnessing nanomedicine for therapeutic intervention in glioblastoma.

    abstract:INTRODUCTION:Glioblastoma is a type of brain cancer arises from glial cells. Glioblastoma multiforme (GBM), a subtype of glioblastoma, is the most common and most aggressive primary brain tumor. Currently, GBM therapy includes surgery and post-operative high-doses of radiation and chemotherapy. This therapeutic strateg...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1200557

    authors: Gutkin A,Cohen ZR,Peer D

    更新日期:2016-11-01 00:00:00

  • Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.

    abstract::Many agents used to treat cancer are toxic to normal tissues. Thus, treatments delivering drug specifically to tumour, while minimising exposure to normal tissue, may be advantageous over non-targeted treatments. The exquisite specificity of the immune system has been used successfully to help develop targeted antican...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.1.87

    authors: Brumlik MJ,Daniel BJ,Waehler R,Curiel DT,Giles FJ,Curiel TJ

    更新日期:2008-01-01 00:00:00

  • A biorelevant dissolution stress test device - background and experiences.

    abstract:IMPORTANCE OF THE FIELD:The prediction of the in vivo drug release characteristics of modified release (MR) oral dosage forms by in vitro dissolution tests is a prerequisite for successful product development. AREAS COVERED IN THIS REVIEW:To improve the predictive power of dissolution testing, the authors recently dev...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.527943

    authors: Garbacz G,Klein S,Weitschies W

    更新日期:2010-11-01 00:00:00

  • Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor.

    abstract:OBJECTIVES:The aim of this work is to synthesize a novel stable and biodegradable nitric oxide (NO) donor polymer based on a chitosan backbone. This polymer needed to be linked to glutathione (GSH), which was nitrosated in a second step. This polymer has been developed as an NO delivery platform that could be further e...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2015.1028916

    authors: Shah SU,Martinho N,Socha M,Pinto Reis C,Gibaud S

    更新日期:2015-08-01 00:00:00

  • Advances in non-invasive drug delivery for atherosclerotic heart disease.

    abstract:INTRODUCTION:Apart from statins, anti-platelet agents and invasive procedures, the anti-atherosclerotic medical weaponry for coronary heart disease (CHD) is scarce and only partially protects CHD patients from major adverse cardiac events. AREAS COVERED:Several novel non-invasive strategies are being developed to wide...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.999663

    authors: Maranhão RC,Tavares ER

    更新日期:2015-07-01 00:00:00

  • Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation.

    abstract:OBJECTIVES:Methotrexate (MTX) is a chemotherapeutic and anti-inflammatory drug that may cause systemic adverse effects. This study investigated kinetics and biodistribution of MTX delivered topically by ablative fractional laser (AFXL). METHODS:In vitro passive diffusion of 10 mg/ml MTX (1 w/v%) was measured from 0.25...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2015.1031216

    authors: Taudorf EH,Lerche CM,Vissing AC,Philipsen PA,Hannibal J,D'Alvise J,Hansen SH,Janfelt C,Paasch U,Anderson RR,Haedersdal M

    更新日期:2015-07-01 00:00:00

  • Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin.

    abstract:BACKGROUND:We hypothesized if phagocytosis of liposomes by macrophages could be mitigated through incorporation of a CD47 mimicry peptide (Self peptide: SP) on the surface of liposomes. METHODS:Thin film hydration method followed by extrusion was used to prepare nanoliposomes, and Dox encapsulation in liposomes was do...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1772749

    authors: Gheibi Hayat SM,Jaafari MR,Hatamipour M,Jamialahmadi T,Sahebkar A

    更新日期:2020-07-01 00:00:00

  • Photosensitiser delivery for photodynamic therapy. Part 1: Topical carrier platforms.

    abstract:BACKGROUND:Photodynamic therapy (PDT) is a medical treatment in which a combination of a photosensitising drug and visible light causes destruction of selected cells. Due to the lack of true selectivity of preformed photosensitisers for neoplastic tissue and their high molecular weights, PDT of superficial skin lesions...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.7.757

    authors: Donnelly RF,McCarron PA,Morrow DI,Sibani SA,Woolfson AD

    更新日期:2008-07-01 00:00:00

  • Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery.

    abstract:INTRODUCTION:Neurodegenerative diseases (NDs) represent a group of different clinical entities that, despite the specific primary etiologies, share a common signature in terms of a general mitochondrial dysfunction with consequent oxidative stress accumulation. As these two events occur early during neurodegenerative p...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1218461

    authors: Pezzini I,Mattoli V,Ciofani G

    更新日期:2017-04-01 00:00:00

  • The biological routes of gene delivery mediated by lipid-based non-viral vectors.

    abstract::Cationic lipid/DNA complexes (lipoplexes) represent an attractive alternative to viral vectors for cell transfection in vitro and in vivo but still suffer from relatively low efficiency. Comprehension of the interactions between vectors and DNA as well as cellular pathways and mechanisms in DNA entry into cells and ul...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903287153

    authors: Duan Y,Zhang S,Wang B,Yang B,Zhi D

    更新日期:2009-12-01 00:00:00

  • Cutaneous immunization: an evolving paradigm in influenza vaccines.

    abstract:INTRODUCTION:Most vaccines are administered by intramuscular injection using a hypodermic needle and syringe. Some limitations of this procedure include reluctance to be immunized because of fear of needlesticks, and concerns associated with the safe disposal of needles after their use. Skin delivery is an alternate ro...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.885947

    authors: Gill HS,Kang SM,Quan FS,Compans RW

    更新日期:2014-04-01 00:00:00

  • A pilot study examining patient preference and satisfaction for ava®, a reusable electronic injection device to administer certolizumab pegol.

    abstract::Background: Anti-tumor necrosis factor (anti-TNF) adherence is suboptimal. ava®, a reusable electromechanical self-injection device (e-Device) developed for certolizumab pegol (CZP) administration, aims to overcome some barriers to increase adherence. This study evaluates patient experience of the e-Device and its tra...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1736552

    authors: Pouls BPH,Kristensen LE,Petersson M,van den Bemt BJF,Ballerini L,Bruggraber R,Karlen H,Mountian I,van Bracht E,Wiegratz S,Jørgensen TS

    更新日期:2020-05-01 00:00:00

  • Tailoring antibodies for radionuclide delivery.

    abstract::Therapeutic antibodies are well established as an important class of drugs in modern medicine. The exquisite specificity and affinity for a specific target offered by antibodies has also encouraged their development as delivery vehicles for agents such as radionuclides to target tissues, for radioimmunoimaging and rad...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.3.1.53

    authors: Kenanova V,Wu AM

    更新日期:2006-01-01 00:00:00

  • Thermoresponsive polymers as gene and drug delivery vectors: architecture and mechanism of action.

    abstract:INTRODUCTION:This topic is important as it allows for improved specificity in drug delivery, providing possibilities for reduced side effects, and thereby improved pharmacotherapy. As a wealth of different polymers and mechanisms of action has been suggested, a systematic overview of the field is of current importance....

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.846906

    authors: Calejo MT,Sande SA,Nyström B

    更新日期:2013-12-01 00:00:00

  • Lymph node metastases: importance of detection and treatment strategies.

    abstract:INTRODUCTION:Lymphatic vessels are the preferential route of most solid tumors to spread their metastases in the body. The onset of metastatic nests in draining lymph nodes (LNs) are a significant indicator of cancer progression and a dismaying sign of worsen staging. Therefore, the individuation and elimination of can...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2018.1446937

    authors: Obinu A,Gavini E,Rassu G,Maestri M,Bonferoni MC,Giunchedi P

    更新日期:2018-05-01 00:00:00

  • Design and in vitro release study of siRNA loaded Layer by Layer nanoparticles with sustained gene silencing effect.

    abstract:OBJECTIVES:Clinical translation of siRNA therapeutics has been severely limited due to the lack of stable and sustained siRNA delivery systems. Furthermore, when nanocarrier systems with siRNA are administered systemically to treat diseases, insufficient doses reach the target tissue. Here we report the successful deve...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2018.1518426

    authors: Tan YF,Lee YS,Seet LF,Ng KW,Wong TT,Venkatraman S

    更新日期:2018-10-01 00:00:00

  • Transdermal immunization: biological framework and translational perspectives.

    abstract:INTRODUCTION:The renaissance in drug delivery research during the past decade led to several new approaches toward vaccine development. Transdermal immunization (TI) is a promising modality with both practical and immunological merits. Compared with conventional routes of administration, this needle-free delivery appro...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.746660

    authors: Mishra DK,Dhote V,Mishra PK

    更新日期:2013-02-01 00:00:00

  • Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.

    abstract:INTRODUCTION:Harnessing RNA interference as a therapeutic approach has the potential to significantly expand the druggable target space, offering new hope for treatment of diseases that cannot be addressed with existing classes of drugs. A number of siRNA therapeutics have already progressed into preclinical and clinic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.642363

    authors: Gindy ME,Leone AM,Cunningham JJ

    更新日期:2012-02-01 00:00:00

  • Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.

    abstract:INTRODUCTION:Transdermal drug delivery has several known advantages over the oral route and hypodermic injections. The number of drugs that can be taken up transdermally is, however, limited owing to the innate barrier function of the skin. New transdermal drug candidates need to be tested extensively before being used...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.568937

    authors: Van Gele M,Geusens B,Brochez L,Speeckaert R,Lambert J

    更新日期:2011-06-01 00:00:00

  • Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.

    abstract::Introduction: Current therapies of neurodegenerative or neurometabolic diseases are, to a large extent, hampered by the inability of drugs to cross the blood-brain barrier (BBB). This very tight barrier severely restricts the entrance of molecules from the blood into the brain, especially macromolecular substances (i....

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1698544

    authors: Tosi G,Duskey JT,Kreuter J

    更新日期:2020-01-01 00:00:00

  • Albumin and its application in drug delivery.

    abstract:INTRODUCTION:Rapid clearance of drugs from the body results in short therapeutic half-life and is an integral property of many protein and peptide-based drugs. To maintain the desired therapeutic effect patients are required to administer higher doses more frequently, which is inconvenient and risks undesirable side ef...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.993313

    authors: Sleep D

    更新日期:2015-05-01 00:00:00

  • Recent updates in utilizing prodrugs in drug delivery (2013-2015).

    abstract:INTRODUCTION:Utilizing the prodrug approach as a method to overcome various pharmaceutical and pharmacokinetic barriers to drug delivery is significantly accelerating and achieving successes. In contrast to the older traditional prodrugs which suffer from decreased bioavailability and a high profile of side effects, du...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2016.1142527

    authors: Amly W,Karaman R

    更新日期:2016-01-01 00:00:00

  • Novel functionalization strategies to improve drug delivery from polymers.

    abstract:INTRODUCTION:The utility of controlled and sustained release of drugs from polymeric systems, both bulk (hydrogels) and colloids (nanoparticles), is a key point that should be addressed. Unfortunately, classic delivery systems are essentially driven by diffusion, which is very quick due to the high concentration gradie...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1285280

    authors: Mauri E,Papa S,Masi M,Veglianese P,Rossi F

    更新日期:2017-11-01 00:00:00

  • Novel hydrofluoroalkane suspension formulations for respiratory drug delivery.

    abstract::Due to the poor solvent properties of hydrofluoroalkanes, suspension is often the only formulation option for respiratory drug delivery. Research in this area has focussed mainly on two main themes over the past 5 years: new design of stabilisers and particle engineering. Among the most important advances, the introdu...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.4.625

    authors: Rogueda P

    更新日期:2005-07-01 00:00:00

  • An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.

    abstract::Introduction: Incorrect inhaler technique is one reason why the efficacies of inhaled asthma treatments in clinical trials and effectiveness in the real world differ. Inhaler technique is critical for drug delivery to the lungs; incorrect technique negatively impacts asthma control and long-term outcomes. Breath-trigg...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1689957

    authors: Usmani O,Roche N,Marshall J,Danagher H,Price D

    更新日期:2019-12-01 00:00:00

  • Preparation of sterile long-acting injectable medroxyprogesterone acetate microcrystals based on anti-solvent precipitation and crystal habit control.

    abstract::Background: To overcome the rigorous aseptic process widely adopted by commercial long-acting injections, this work aimed to prepare a sterile MPA injection by manipulating the crystal habit through a bottom-up method. Methods: The habit of the precipitated crystals was modified by changing the process conditions. Whe...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2019.1662394

    authors: Sun R,Guo Y,Yin N,Yin J,Yin T,He H,Gou J,Zhang Y,Tang X

    更新日期:2019-10-01 00:00:00

  • Physicochemical and physiological considerations for efficient nose-to-brain targeting.

    abstract:INTRODUCTION:Nasal drug delivery that exploits the olfactory and trigeminal neuronal pathways to deliver drugs to the brain is being widely explored by pharmaceutical companies, for the delivery of challenging drugs. Low-molecular-weight and lipophilic drugs are effectively absorbed by the intranasal route for efficaci...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.636801

    authors: Bahadur S,Pathak K

    更新日期:2012-01-01 00:00:00

  • Process optimization for the production of nanoparticles for drug delivery applications.

    abstract::Various techniques have been developed to prepare nanoparticles for the delivery of drugs. The implementation of these techniques for large-scale production is still in its infancy, as it requires defined steps which include excipient compatibility, process feasibility, formulation optimization, process optimization, ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902735806

    authors: Saraf S

    更新日期:2009-02-01 00:00:00

  • Preclinical models for pulmonary drug delivery.

    abstract:BACKGROUND:The lung comprises an interesting route of administration not only for topical drugs but also for systemically acting drugs. Over the last years, several models have been developed in order to study the efficacy and safety of pulmonary drug delivery. OBJECTIVE:This review describes relevant drug delivery mo...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903241788

    authors: Fernandes CA,Vanbever R

    更新日期:2009-11-01 00:00:00

  • Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.

    abstract:INTRODUCTION:Recent developments in ultrasound imaging and ultrasound contrast agents (UCAs) improved diagnostic confidence in echography and set into motion their combined use as a tool for drug delivery and therapeutic monitoring. Non-invasive, precise and targeted delivery of drug molecules to pathological tissues b...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1266328

    authors: Sennoga CA,Kanbar E,Auboire L,Dujardin PA,Fouan D,Escoffre JM,Bouakaz A

    更新日期:2017-09-01 00:00:00